Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma

ABSTRACT:

SUBMITTER: Aoki T 

PROVIDER: S-EPMC10857830 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature